Novavax, Inc.
NVAX
Market Cap$1.19B
Close$
$24.78
254.6% upside
Current Fair Value
254.6% upsideUndervalued by 254.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.19 Billion |
|---|---|
| Enterprise Value | $1.30 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.23 |
| Beta | 3.21 |
| Outstanding Shares | 161,049,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.47 |
|---|---|
| PEG | -0.55 |
| Price to Sales | 1.0 |
| Price to Book Ratio | -6.99 |
| Enterprise Value to Revenue | 1.03 |
| Enterprise Value to EBIT | 2.72 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | -4.91 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck